ACT	Adoptive cell therapy
ADCC	Antibody-dependent cell cytotoxicity
APCs	Antigen-presenting cells
AMF	Alternating magnetic field
αβ T	Alpha beta T
BCR	B cell receptor
BNF	Bionized nanoferrite
CARs	Chimeric antigen receptors
CAR-T	Chimeric antigen receptor-T cell
CpG ODN	CpG oligodeoxynucleotides
CTLA-4	Cytotoxic T-lymphocyte antigen-4
DAMPs	Damage-associated molecular patterns
DCs	Dendritic cells
DNA	Deoxyribonucleic acid
ECM	Extracellular matrix
EGFR	Epidermal growth factor receptor
EPR	Enhanced permeability and retention
FDA	Food and Drug Administration
GM-CSF	Granulocyte–macrophage colony-stimulating factor
γδ T	Gamma delta T
HMGB1	High-mobility group box 1
HSP	Heat-shock protein
ICB	Immune checkpoint blockade
ICD	Immunogenic cell death
IFN-γ	Interferon gamma
IL	Interleukin
MDSCs	Myeloid-derived suppressor cells
MHC	Major histocompatibility complex
MHT	Magnetic hyperthermia therapy
MNPs	Magnetic nanoparticles
MPI	Magnetic particle imaging
mPEG-PLGA	Poly(ethylene glycol)-block-poly(lactic-co-glycolic acid)
MRI	Magnetic resonance imaging
NF-κB	Nuclear factor-κB
NIR	Near infrared
NK	Natural killer
OVA	Ovalbumin
PAMPs	Pathogen-associated molecular patterns
PBLs	Peripheral blood lymphocytes
PDA	Polydopamine
pDNA	Plasmid deoxyribonucleic acid
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
PD	Photodynamic therapy
PEI	Polyethyleneimine
poly(I:C)	Polyinosinic:polycytidylic acid
PRRs	Pattern recognition receptors
RNA	Ribonucleic acid
siRNA	Small interfering ribonucleic acid
SAR	Specific absorption rate
SPs	Superparticles
SPION	Superparamagnetic iron oxide nanoparticle
TAAs	Tumour-associated antigens
TAMs	Tumour-associated macrophages
TCR	T-cell receptor
TILs	Tumour-infiltrating lymphocytes
TME	Tumour microenvironment
TNF-α	Tumour necrosis factor alpha
TGF-β	Transforming growth factor-beta
Th	T helper
TLR	Toll-like receptor
Tregs	Regulatory T-cells